UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000027481
Receipt No. R000031481
Official scientific title of the study Randomized study of Sokei-Kakketsu-To for the Reduction of Aromatase Inhibitor - Associated Joint Symptoms in Women with Breast Cancer
Date of disclosure of the study information 2017/05/25
Last modified on 2019/01/07 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Randomized study of Sokei-Kakketsu-To for the Reduction of Aromatase Inhibitor - Associated Joint Symptoms in Women with Breast Cancer
Title of the study (Brief title) Randomized study of Sokei-Kakketsu-To for the Reduction of Aromatase Inhibitor - Associated Joint Symptoms
Region
Japan

Condition
Condition Breast Cancer
Classification by specialty
Hematology and clinical oncology Breast surgery Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Validation of Sokei-Kakketsu-To (TJ-53) for the reduction of aromatase inhibitor associated joint symptoms in women with breast cancer
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Effectiveness in the treatment of TJ-53 to the aromatase inhibitor associated joint symptoms at 3 months. HAQ-DI (Health Assessment Questionnaire-Disability Index) will be used for the assessment of the effectiveness.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification YES
Dynamic allocation
Institution consideration
Blocking YES
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine Behavior,custom
Interventions/Control_1 Oral treatment of Sokei-Kakketsu-To(TJ-53) for 3 months
Interventions/Control_2 Joint exercises
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >
Gender Female
Key inclusion criteria Breast cancer patients treated with Aromatase inhibitor(any of Aromatase Inhibitors: Letrozole, Anastrozole and Exemestane) who developed joint symptoms or worsend the symptoms
Key exclusion criteria 1. Patients having neurological disorder, collagen disease and orthopedic disease who show the similar joint symptoms.
2. Patients treated with medicine that may affect the joint symptoms (NSAIDs, Acetaminophen or Opioids etc.)
Target sample size 68

Research contact person
Name of lead principal investigator Shinji Ozaki
Organization National Hospital Organization Kure Medical Center/Chugoku Cancer Center
Division name Department of Breast Surgery
Address 3-1 Aoyama-cho, Kure-shi, Hiroshima, JAPAN, 737-0023
TEL 0823-22-3111
Email ozakis@kure-nh.go.jp

Public contact
Name of contact person Shinji Ozaki
Organization National Hospital Organization Kure Medical Center/Chugoku Cancer Center
Division name Department of Breast Surgery
Address 3-1 Aoyama-cho, Kure-shi, Hiroshima, JAPAN, 737-0023
TEL 0823-22-3111
Homepage URL
Email ozakis@kure-nh.go.jp

Sponsor
Institute National Hospital Organization Kure Medical Center/Chugoku Cancer Center
Institute
Department

Funding Source
Organization National Hospital Organization Kure Medical Center/Chugoku Cancer Center
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 05 Month 25 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2017 Year 05 Month 09 Day
Anticipated trial start date
2017 Year 05 Month 19 Day
Last follow-up date
2022 Year 06 Month 30 Day
Date of closure to data entry
2024 Year 12 Month 31 Day
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 05 Month 24 Day
Last modified on
2019 Year 01 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031481